Vitreous & Retina Consultants entered the industry of Ophthalmologists in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $10.000.000 to $19.9999.999. The NAICS classifies this business under the code 6211110, which describes it as a Ophthalmologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Ophthalmologists. The business provides service to the B2C market.
To acquire more information, please contact David Misch, Owner by calling (863) 686-9486 during business hours. You can also write to the business’ Single Location at 2815 Lakeland Hills Boulevard # 200, Lakeland, Florida FL 33805. You can also visit the company’s website at maculardegeneration.net. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Vitreous & Retina Consultants |
Representative: | David Misch, Owner |
Place of Business: | 2815 Lakeland Hills Boulevard # 200, Lakeland, FL 33805 |
Contact Number: | (863) 686-9486 |
Website: | maculardegeneration.net |
Type of Service: | Ophthalmologists |
SIC Number: | 8011 |
NAICS Number: | 6211110 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Income/Year: | $10.000.000 to $19.9999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Vitreous & Retina Consultants is a company operating from Polk, Florida providing professional Ophthalmologists and relevant B2C variables. It was founded in 0 and registered with the SIC code 8011 as Ophthalmologists, and with the NAICS code 6211110 as Ophthalmologists.
With a current employee count of 1 to 4, Vitreous & Retina Consultants has gone to report making $10.000.000 to $19.9999.999 per annum on its journey towards growth. This company invites you to contact its representative David Misch, Owner at (863) 686-9486 for related queries, or to locate its Single Location using the coordinates 28.0784,-81.95322.
The Single Location can also be found at the street address 2815 Lakeland Hills Boulevard # 200 in Lakeland, Florida 33805 and can be engaged online through the company website at maculardegeneration.net, the company Twitter , and Facebook page .